Erymax 250mg (Erythromycin Delayed-Release 250 mg)
Pill with imprint Erymax 250mg is Orange / Clear, Capsule-shape and has been identified as Erythromycin Delayed-Release 250 mg. It is supplied by Midlothian Laboratories.
Erythromycin is used in the treatment of dental abscess; skin or soft tissue infection; upper respiratory tract infection; bronchitis; bacterial endocarditis prevention (and more), and belongs to the drug class macrolides. There is no proven risk in humans during pregnancy. Erythromycin 250 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for Erymax 250mg
Erythromycin Delayed-Release
- Imprint:
- Erymax 250mg
- Strength:
- 250 mg
- Color:
- Orange / Clear
- Shape:
- Capsule-shape
- Availability:
- Prescription only
- Drug Class:
- Macrolides
- Pregnancy Category:
- B - No proven risk in humans
- CSA Schedule:
- Not a controlled drug
- Labeler / Supplier:
- Midlothian Laboratories
- National Drug Code (NDC):
- 68308-0250
More about erythromycin
- Erythromycin Side Effects
- During Pregnancy or Breastfeeding
- Dosage Information
- Drug Images
- Drug Interactions
- Compare Alternatives
- Support Group
- Pricing & Coupons
- En Español
- 30 Reviews
- Drug class: macrolides
Consumer resources
- Erythromycin
- Erythromycin Delayed-Release Tablets and Capsules
- Erythromycin Tablets
- Erythromycin Injection
- Erythromycin Suspension
- ... +2 more
Other brands: Erythrocin, Ery-Tab, EryPed, Ilosone, ... +4 more
Professional resources
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
